500 patients to test if daily azithromycin keeps bronchiectasis attacks at bay
NCT ID NCT07608328
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether taking a low dose of the antibiotic azithromycin every day for a year can reduce the number of serious lung infection flare-ups in adults with non-CF bronchiectasis. About 500 participants will receive either azithromycin or a placebo pill, added to their usual care. The goal is to see if this simple daily pill can help control the disease and prevent worsening episodes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRONCHIECTASIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Assiut university-Faculty of Medicine
Asyut, 71515, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gum treatment may lower lung flare-ups in bronchiectasis patients
- Can mapping patient profiles unlock better breathing therapy for bronchiectasis?
- Can a daily pill cut dangerous lung Flare-Ups in bronchiectasis?
- Can an inhaled drug ease bronchiectasis? a trial seeks answers
- Breathing and qigong: a drug-free approach to easier breathing for damaged lungs?
- A vibrating vest may help children with damaged lungs breathe easier